Developer docs
API playgroundTry for free, no card

Search company profiles

Tata Memorial Hospital

Full company profile

uuid000al7p

Namestring
Tata Memorial Hospital
Legal namestring
Tata Memorial Centre
Websiteurl
tmc.gov.in
Company typeenum
Private
Founded yearint
1941
Descriptiontext

Tata Memorial Centre (TMC) is a Grant-in-Aid Institution under the Department of Atomic Energy, Government of India, founded in 1941 and headquartered in Mumbai. It operates as India's premier public-sector cancer institution, delivering multidisciplinary oncology care, education, and clinical research through a hub-and-spoke footprint of 11 hospitals across 7 Indian states (Maharashtra, Punjab, Uttar Pradesh, Bihar, Andhra Pradesh, Assam, with Odisha under construction). The flagship Tata Memorial Hospital (TMH) in Mumbai has been in operation for over 80 years, supported by affiliated centres including ACTREC and CCE in Navi Mumbai and the National Cancer Grid — a network of 300+ cancer centres, research institutions, and professional societies.

The institution's core operating model is built on Disease Management Groups (DMGs) — multidisciplinary teams of expert clinicians dedicated to specific cancer types — and is supported by a digital infrastructure that includes cross-centre Electronic Medical Records, an online patient registration portal (ABHA) for new registrations, second opinions, teleconsultation, preventive oncology, and referral investigations, plus a specialized Digital Library with e-resource access via the MyLOFT app. Research is delivered through the Clinical Research Secretariat (CRS, established 1997, DAE Clinical Trial Centre since 2003), two Institutional Ethics Committees (IEC-I and IEC-II) recognized by WHO SIDCER/FERCAP and NABH-accredited, and academic programs affiliated to Homi Bhabha National Institute (HBNI) covering super-specialty M.Ch/DM, postgraduate MD/MSc, PhD, and 25 oncology fellowship streams. Additional offerings include the KEVAT Patient Navigation Program (developed with TISS), an International Patient Advisor office, and a Hospital Statistics Dashboard providing real-time KPI transparency.

TMC's revenue model is anchored in Government Grant-in-Aid from the Department of Atomic Energy, supplemented by patient service fees (with international patients on F-Category pricing requiring ₹50,000 registration and ₹2,00,000 admission deposits), revenue from pharmaceutical-sponsored clinical trials (IEC fees of Rs. 40,000 + GST per initial submission), donations eligible for IT exemptions under Section 80G and 35(1)(ii), and CSR contributions via Tata Trusts. The institution registers approximately 120,000 new cancer patients and 450,000 follow-up patients annually, and recorded 572,863+ OPD visits, 5,238 major surgeries, and 52,228 radiotherapy sessions in 2026 YTD — positioning TMC among the highest-volume cancer care providers globally.

Short descriptiontext

Tata Memorial Centre is a Government of India cancer institution operating 11 hospitals across 7 states, delivering multidisciplinary oncology care, research, and education to over 120,000 new patients annually under the Department of Atomic Energy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParel, India
HQ citystring
Parel
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, oncology hospital care, medical education programs, clinical research services, cancer epidemiology research
Industry1 code
1Hospital-Based Palliative Care (Inpatient Consult Services)
CodeHLADAHAGPrimaryYes
NAICS code1 code
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code3 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
  • Services-Health Services8000
Product category
Cancer Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Government Grant-in-Aid
TypeSubscription Recurring
Description

Tata Memorial Centre operates as a Grant-in-Aid Institution under the Department of Atomic Energy, Government of India, receiving primary funding from the government for operations, infrastructure, and expansion

tmc.gov.in
2Patient Service Fees
TypeTransaction Fee
Description

Fees charged to patients for consultations, treatments, surgeries, radiotherapy, and other medical services. International patients are charged under F Category as per the Schedule of Charges

tmc.gov.in
3Research Grants and Sponsored Studies
TypeProfessional Services
Description

Revenue from pharmaceutical-sponsored clinical trials and studies, with IEC processing fees of Rs. 40,000 + GST for initial project submissions and Rs. 10,000 + GST for amendments

tmc.gov.in
4Donations and CSR Contributions
TypeAffiliate Referral
Description

Donations from individuals and organizations for research, patient welfare, and facility development. Donations eligible for IT exemptions under Section 80G and 35(1)(ii)

tmc.gov.in
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details3 tiers
1International Patient Registration Deposit
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

₹50,000 refundable deposit at time of registration

tmc.gov.in
2International Patient Admission Deposit
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

₹2,00,000 refundable deposit at time of hospital admission

tmc.gov.in
3IEC Project Submission Fee (Pharma Sponsored)
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Initial project submission: Rs. 40,000 + applicable GST; Protocol amendment/revision: Rs. 10,000 + applicable GST

tmc.gov.in
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1KEVAT - Patient Navigation Program
Description

One year full time Post Graduate Diploma in Patient Navigation, developed in collaboration with Tata Institute of Social Sciences (TISS) and with support from Tata Trusts. First academic program in India for patient navigation in oncology care.

tmc.gov.in
Core offering1 text field

Tata Memorial Centre provides comprehensive cancer care encompassing diagnosis, surgery, radiotherapy, chemotherapy, and palliative care delivered through Disease Management Groups (DMGs) across 11 hospitals in 7 Indian states. Beyond clinical service, it operates postgraduate medical education programs affiliated to Homi Bhabha National Institute (HBNI), runs the Clinical Research Secretariat supporting investigator-initiated and sponsored trials, maintains SIDCER/FERCAP-recognized Institutional Ethics Committees, and offers international patient coordination through a dedicated IPA office.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 120,000 new cancer patients registered annually across all TMC centres
+3 more records
Product overview1 text field

Tata Memorial Hospital operates as a multi-unit cancer care institution under the Department of Atomic Energy, Government of India. The hospital offers a comprehensive ecosystem of cancer care services organized through Disease Management Groups (DMGs), supported by digital infrastructure including E-Medical Records, Online Registration Portal, and Hospital Statistics systems. The institution provides extensive medical education through HBNI-affiliated programs (super-speciality M.Ch/DM degrees, MD programs, M.Sc courses, and 25 oncology fellowships), patient navigation services (KEVAT program), clinical research support via the CRS department, ethics oversight through NABH-accredited IECs, and a specialized digital library with e-resource access. Patient-facing digital services include teleconsultation, second opinion services, and EMR access across multiple regional centers. The hospital's research infrastructure includes a Clinical Research Secretariat, institutional ethics committees recognized by WHO SIDCER, and access to academic conferences and training programs.

Product and service9 records
1E-Medical Records (EMR)
CategoryDigital Patient Service
Description

Electronic Medical Records system enabling digital patient health records, accessible across multiple TMC centres including TMH Mumbai, HBCH Sangrur, MPMMCC Varanasi, HBCHRC Vizag, BBCI Guwahati, and HBCHRC Muzaffarpur.

2Online Patient Registration Portal (ABHA)
CategoryDigital Patient Service
Description

Digital registration platform offering New Patient Registration for diagnosed cancer patients, Expert Second Opinion consultations, Preventive Oncology services, Referral Investigation processing, and Teleconsultation for telephone/video consultations.

3International Patient Services
CategoryPatient Care Service
Description

Dedicated services for international patients including visa invitation letters, AYUSH registration support, International Patient Advisor coordination, and F-category billing per the Schedule of Charges.

4Patient Navigation Program (KEVAT)
CategoryMedical Education Program
Description

One-year full-time Post Graduate Diploma in Patient Navigation developed in collaboration with Tata Institute of Social Sciences (TISS), with support from Tata Trusts, providing trained professionals to help cancer patients navigate diagnosis, treatment, and survivorship care.

5Medical Education Programs
CategoryMedical Education Program
Description

Comprehensive academic offerings affiliated to Homi Bhabha National Institute (HBNI), including super-speciality courses (M.Ch, DM), post-graduate degrees (MD, MSc), paramedical programs, and 25 oncology subspecialty fellowships.

6Clinical Research Secretariat (CRS)
CategoryClinical Research Service
Description

Department of Atomic Energy Clinical Trial Centre supporting investigator-initiated trials, sponsored studies, and collaborative research from protocol development through participant recruitment with biostatistical support.

7Institutional Ethics Committees (IEC) Review Service
CategoryEthics Review Service
Description

Two IEC committees (IEC-I and IEC-II) providing independent scientific and ethical review of research proposals, recognized by WHO SIDCER/FERCAP and NABH accredited. Initial submission fee Rs. 40,000 + GST; amendment fee Rs. 10,000 + GST.

8Oncology Conferences and Training Programs
CategoryConference and Training Program
Description

Annual conferences, workshops, and training programs in oncology including events like ONCOSURG (Live Surgical Oncology Workshop), GCP courses, and specialized masterclasses in pediatric oncology, critical care, and palliative care.

9NABL Accredited Service Directory
CategoryDiagnostic and Ancillary Service
Description

Comprehensive service directory with NABL accreditation providing information on all hospital departments and ancillary services across TMC.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

MoU signed to establish 'Cancer Research & Innovation Centre' for advancing cancer research and innovation in diagnostics and treatment technologies

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration to offer one-year full-time Post Graduate Diploma in Patient Navigation (KEVAT) - the first such program in India

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Designated as UICC coordination centre for professional cancer education for Asia-Pacific regions

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

TMC-organized network of 300+ cancer centres, research institutions, patient groups, charitable organizations, and professional societies working to provide uniform standards of cancer care

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India's largest dedicated cancer care network, operating multiple cancer hospitals and treatment centres across the country. HCG is the closest direct competitor to TMC in Indian oncology, with a comparable focus on multi-modality cancer treatment, though delivered through a private, publicly-listed model.

TypeBroad incumbent
Description

A leading private hospital chain in North India with significant oncology programs. Max is comparable to TMC in tertiary care delivery, medical education, and research, with overlapping catchment in northern India — though oncology is one of several specialties.

TypeBroad incumbent
Description

India's largest private hospital chain, operating tertiary multi-specialty hospitals including dedicated Apollo Cancer Institutes across multiple cities. Apollo is a broad incumbent peer because it competes with TMC on oncology volumes, talent, and referrals, though cancer is one specialty within its broader multi-specialty portfolio.

TypeBroad incumbent
Description

A large private multi-specialty hospital chain in India with cancer centres at major locations. Fortis competes for oncology patients and clinicians, and is comparable to TMC's hub-and-spoke hospital model, though as a broader multi-specialty operator rather than a cancer-only institution.

TypeDirect peer
Description

A leading not-for-profit specialty cancer hospital in Delhi NCR providing comprehensive cancer diagnosis, treatment, research, and education. It is directly comparable to TMC as a dedicated cancer hospital with academic and research programs, though with a narrower geographic footprint.

TypeDirect peer
Description

A premier public-sector academic medical institution providing tertiary care, oncology services, and postgraduate medical education. PGIMER is a direct public-sector peer to TMC with overlapping academic, clinical, and research mandates at national scale.

7Tata Memorial Hospital — AIIMS (All India Institute of Medical Sciences)
TypeDirect peer
Description

India's flagship public-sector tertiary care and academic medical institution. AIIMS is a direct peer to TMC as a premier government-funded academic medical centre, with overlapping oncology services, large patient volumes, and a national training and research mandate.

TypeBroad incumbent
Description

A leading US specialty cancer hospital and research institution with a long legacy in oncology care, research, and education. MSK is comparable to TMC in mission, multidisciplinary disease-site specialisation, and academic standing, and serves as a global reference point for TMC's research and clinical programs.

TypeDirect peer
Description

One of India's oldest and most respected tertiary care academic medical institutions, with strong oncology services, large patient volumes, and an academic and research mandate. CMC is directly comparable to TMC in mission, scale of teaching/research, and patient mix.

TypeBroad incumbent
Description

The world's largest cancer-focused hospital and research centre, based in Houston, Texas. MD Anderson is comparable to TMC as a global benchmark for specialty cancer hospitals with deep research, training, and multidisciplinary Disease Management Group-style care models.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tata Memorial Hospital

Cancer Hospital Servicestmc.gov.in

Tata Memorial Centre is a Government of India cancer institution operating 11 hospitals across 7 states, delivering multidisciplinary oncology care, research, and education to over 120,000 new patients annually under the Department of Atomic Energy.

What Tata Memorial Hospital does

Tata Memorial Centre (TMC) is a Grant-in-Aid Institution under the Department of Atomic Energy, Government of India, founded in 1941 and headquartered in Mumbai. It operates as India's premier public-sector cancer institution, delivering multidisciplinary oncology care, education, and clinical research through a hub-and-spoke footprint of 11 hospitals across 7 Indian states (Maharashtra, Punjab, Uttar Pradesh, Bihar, Andhra Pradesh, Assam, with Odisha under construction). The flagship Tata Memorial Hospital (TMH) in Mumbai has been in operation for over 80 years, supported by affiliated centres including ACTREC and CCE in Navi Mumbai and the National Cancer Grid — a network of 300+ cancer centres, research institutions, and professional societies.

The institution's core operating model is built on Disease Management Groups (DMGs) — multidisciplinary teams of expert clinicians dedicated to specific cancer types — and is supported by a digital infrastructure that includes cross-centre Electronic Medical Records, an online patient registration portal (ABHA) for new registrations, second opinions, teleconsultation, preventive oncology, and referral investigations, plus a specialized Digital Library with e-resource access via the MyLOFT app. Research is delivered through the Clinical Research Secretariat (CRS, established 1997, DAE Clinical Trial Centre since 2003), two Institutional Ethics Committees (IEC-I and IEC-II) recognized by WHO SIDCER/FERCAP and NABH-accredited, and academic programs affiliated to Homi Bhabha National Institute (HBNI) covering super-specialty M.Ch/DM, postgraduate MD/MSc, PhD, and 25 oncology fellowship streams. Additional offerings include the KEVAT Patient Navigation Program (developed with TISS), an International Patient Advisor office, and a Hospital Statistics Dashboard providing real-time KPI transparency.

TMC's revenue model is anchored in Government Grant-in-Aid from the Department of Atomic Energy, supplemented by patient service fees (with international patients on F-Category pricing requiring ₹50,000 registration and ₹2,00,000 admission deposits), revenue from pharmaceutical-sponsored clinical trials (IEC fees of Rs. 40,000 + GST per initial submission), donations eligible for IT exemptions under Section 80G and 35(1)(ii), and CSR contributions via Tata Trusts. The institution registers approximately 120,000 new cancer patients and 450,000 follow-up patients annually, and recorded 572,863+ OPD visits, 5,238 major surgeries, and 52,228 radiotherapy sessions in 2026 YTD — positioning TMC among the highest-volume cancer care providers globally.

Tata Memorial Hospital firmographics

Firmographics
Name
Tata Memorial Hospital
Legal name
Tata Memorial Centre
Website
https://tmc.gov.in
Company type
Private
Founded year
1941
Operating status
Operating
Headcount range
11–50 employees
Short description
Tata Memorial Centre is a Government of India cancer institution operating 11 hospitals across 7 states, delivering multidisciplinary oncology care, research, and education to over 120,000 new patients annually under the Department of Atomic Energy.
Ownership category
akta.pro rank

Tata Memorial Hospital industry classification

Industry
Product category
Cancer Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Health Services (8000)
akta.pro primary industry
Hospital-Based Palliative Care (Inpatient Consult Services) (HLADAHAG)

Keywords

  • Cancer treatment services
  • Oncology hospital care
  • Medical education programs
  • Clinical research services
  • Cancer epidemiology research

Where Tata Memorial Hospital is headquartered

Location

Headquarters

HQ city
Parel
HQ country
India
HQ region
Asia

Offices10 records

Markets served

Tata Memorial Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Government Grant-in-Aid: Tata Memorial Centre operates as a Grant-in-Aid Institution under the Department of Atomic Energy, Government of India, receiving primary funding from the government for operations, infrastructure, and expansion
  2. Patient Service Fees: Fees charged to patients for consultations, treatments, surgeries, radiotherapy, and other medical services. International patients are charged under F Category as per the Schedule of Charges
  3. Research Grants and Sponsored Studies: Revenue from pharmaceutical-sponsored clinical trials and studies, with IEC processing fees of Rs. 40,000 + GST for initial project submissions and Rs. 10,000 + GST for amendments
  4. Donations and CSR Contributions: Donations from individuals and organizations for research, patient welfare, and facility development. Donations eligible for IT exemptions under Section 80G and 35(1)(ii)

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goInternational Patient Registration Deposit
One time/ perpetual licensePay-as-you-goInternational Patient Admission Deposit
Transaction based/ take ratePay-as-you-goIEC Project Submission Fee (Pharma Sponsored)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Tata Memorial Hospital product offering

Product offering

Core offering

Tata Memorial Centre provides comprehensive cancer care encompassing diagnosis, surgery, radiotherapy, chemotherapy, and palliative care delivered through Disease Management Groups (DMGs) across 11 hospitals in 7 Indian states. Beyond clinical service, it operates postgraduate medical education programs affiliated to Homi Bhabha National Institute (HBNI), runs the Clinical Research Secretariat supporting investigator-initiated and sponsored trials, maintains SIDCER/FERCAP-recognized Institutional Ethics Committees, and offers international patient coordination through a dedicated IPA office.

Product overview

Tata Memorial Hospital operates as a multi-unit cancer care institution under the Department of Atomic Energy, Government of India. The hospital offers a comprehensive ecosystem of cancer care services organized through Disease Management Groups (DMGs), supported by digital infrastructure including E-Medical Records, Online Registration Portal, and Hospital Statistics systems. The institution provides extensive medical education through HBNI-affiliated programs (super-speciality M.Ch/DM degrees, MD programs, M.Sc courses, and 25 oncology fellowships), patient navigation services (KEVAT program), clinical research support via the CRS department, ethics oversight through NABH-accredited IECs, and a specialized digital library with e-resource access. Patient-facing digital services include teleconsultation, second opinion services, and EMR access across multiple regional centers. The hospital's research infrastructure includes a Clinical Research Secretariat, institutional ethics committees recognized by WHO SIDCER, and access to academic conferences and training programs.

Differentiator

Problem solved

Functional benefit

Brands

  • KEVAT - Patient Navigation Program: One year full time Post Graduate Diploma in Patient Navigation, developed in collaboration with Tata Institute of Social Sciences (TISS) and with support from Tata Trusts. First academic program in India for patient navigation in oncology care.

Products and services

  • E-Medical Records (EMR) Electronic Medical Records system enabling digital patient health records, accessible across multiple TMC centres including TMH Mumbai, HBCH Sangrur, MPMMCC Varanasi, HBCHRC Vizag, BBCI Guwahati, and HBCHRC Muzaffarpur.
  • Online Patient Registration Portal (ABHA) Digital registration platform offering New Patient Registration for diagnosed cancer patients, Expert Second Opinion consultations, Preventive Oncology services, Referral Investigation processing, and Teleconsultation for telephone/video consultations.
  • International Patient Services Dedicated services for international patients including visa invitation letters, AYUSH registration support, International Patient Advisor coordination, and F-category billing per the Schedule of Charges.
  • Patient Navigation Program (KEVAT) One-year full-time Post Graduate Diploma in Patient Navigation developed in collaboration with Tata Institute of Social Sciences (TISS), with support from Tata Trusts, providing trained professionals to help cancer patients navigate diagnosis, treatment, and survivorship care.
  • Medical Education Programs Comprehensive academic offerings affiliated to Homi Bhabha National Institute (HBNI), including super-speciality courses (M.Ch, DM), post-graduate degrees (MD, MSc), paramedical programs, and 25 oncology subspecialty fellowships.
  • Clinical Research Secretariat (CRS) Department of Atomic Energy Clinical Trial Centre supporting investigator-initiated trials, sponsored studies, and collaborative research from protocol development through participant recruitment with biostatistical support.
  • Institutional Ethics Committees (IEC) Review Service Two IEC committees (IEC-I and IEC-II) providing independent scientific and ethical review of research proposals, recognized by WHO SIDCER/FERCAP and NABH accredited. Initial submission fee Rs. 40,000 + GST; amendment fee Rs. 10,000 + GST.
  • Oncology Conferences and Training Programs Annual conferences, workshops, and training programs in oncology including events like ONCOSURG (Live Surgical Oncology Workshop), GCP courses, and specialized masterclasses in pediatric oncology, critical care, and palliative care.
  • NABL Accredited Service Directory Comprehensive service directory with NABL accreditation providing information on all hospital departments and ancillary services across TMC.

Quantifiable outcome

  • 120,000 new cancer patients registered annually across all TMC centres
  • +3 more outcomes

Companies that use Tata Memorial Hospital

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Tata Memorial Hospital technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Tata Memorial Hospital partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • GE HealthCarecoreStrategic or Co-development Partner · 1 January 2025MoU signed to establish 'Cancer Research & Innovation Centre' for advancing cancer research and innovation in diagnostics and treatment technologies
  • Tata Institute of Social Sciences (TISS)coreStrategic or Co-development PartnerCollaboration to offer one-year full-time Post Graduate Diploma in Patient Navigation (KEVAT) - the first such program in India
  • UICC (International Union Against Cancer)flagshipStrategic or Co-development PartnerDesignated as UICC coordination centre for professional cancer education for Asia-Pacific regions
  • National Cancer GridflagshipStrategic or Co-development PartnerTMC-organized network of 300+ cancer centres, research institutions, patient groups, charitable organizations, and professional societies working to provide uniform standards of cancer care

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Tata Memorial Hospital competitors and assessment

Company assessment

Direct peers

  • HealthCare Global Enterprises (HCG): India's largest dedicated cancer care network, operating multiple cancer hospitals and treatment centres across the country. HCG is the closest direct competitor to TMC in Indian oncology, with a comparable focus on multi-modality cancer treatment, though delivered through a private, publicly-listed model.
  • Rajiv Gandhi Cancer Institute and Research Centre: A leading not-for-profit specialty cancer hospital in Delhi NCR providing comprehensive cancer diagnosis, treatment, research, and education. It is directly comparable to TMC as a dedicated cancer hospital with academic and research programs, though with a narrower geographic footprint.
  • Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh: A premier public-sector academic medical institution providing tertiary care, oncology services, and postgraduate medical education. PGIMER is a direct public-sector peer to TMC with overlapping academic, clinical, and research mandates at national scale.
  • Tata Memorial Hospital — AIIMS (All India Institute of Medical Sciences): India's flagship public-sector tertiary care and academic medical institution. AIIMS is a direct peer to TMC as a premier government-funded academic medical centre, with overlapping oncology services, large patient volumes, and a national training and research mandate.
  • Christian Medical College (CMC) Vellore: One of India's oldest and most respected tertiary care academic medical institutions, with strong oncology services, large patient volumes, and an academic and research mandate. CMC is directly comparable to TMC in mission, scale of teaching/research, and patient mix.

Broad incumbents

  • Max Healthcare Institute: A leading private hospital chain in North India with significant oncology programs. Max is comparable to TMC in tertiary care delivery, medical education, and research, with overlapping catchment in northern India — though oncology is one of several specialties.
  • Apollo Hospitals Enterprise: India's largest private hospital chain, operating tertiary multi-specialty hospitals including dedicated Apollo Cancer Institutes across multiple cities. Apollo is a broad incumbent peer because it competes with TMC on oncology volumes, talent, and referrals, though cancer is one specialty within its broader multi-specialty portfolio.
  • Fortis Healthcare: A large private multi-specialty hospital chain in India with cancer centres at major locations. Fortis competes for oncology patients and clinicians, and is comparable to TMC's hub-and-spoke hospital model, though as a broader multi-specialty operator rather than a cancer-only institution.
  • Memorial Sloan Kettering Cancer Center: A leading US specialty cancer hospital and research institution with a long legacy in oncology care, research, and education. MSK is comparable to TMC in mission, multidisciplinary disease-site specialisation, and academic standing, and serves as a global reference point for TMC's research and clinical programs.
  • MD Anderson Cancer Center: The world's largest cancer-focused hospital and research centre, based in Houston, Texas. MD Anderson is comparable to TMC as a global benchmark for specialty cancer hospitals with deep research, training, and multidisciplinary Disease Management Group-style care models.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Tata Memorial Hospital social profiles

Digital presence

Tata Memorial Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tata Memorial Hospital leadership team

Management profile

Number of profiles

Profiles11 records

Tata Memorial Hospital subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Tata Memorial Hospital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tata Memorial Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tata Memorial Hospital

What does Tata Memorial Hospital do?

Tata Memorial Centre provides comprehensive cancer care encompassing diagnosis, surgery, radiotherapy, chemotherapy, and palliative care delivered through Disease Management Groups (DMGs) across 11 hospitals in 7 Indian states. Beyond clinical service, it operates postgraduate medical education programs affiliated to Homi Bhabha National Institute (HBNI), runs the Clinical Research Secretariat supporting investigator-initiated and sponsored trials, maintains SIDCER/FERCAP-recognized Institutional Ethics Committees, and offers international patient coordination through a dedicated IPA office.

Is Tata Memorial Hospital a public or private company?

Tata Memorial Hospital is a private company. It is classified as state government owned and is currently operating.

When was Tata Memorial Hospital founded?

Tata Memorial Hospital was founded in 1941. It employs 11 to 50 people.

Where is Tata Memorial Hospital based?

Tata Memorial Hospital is headquartered in Parel, India, in the Asia region.

How does Tata Memorial Hospital make money?

Four revenue lines are on record. Government Grant-in-Aid is the primary driver. The others are patient Service Fees, research Grants and Sponsored Studies and donations and CSR Contributions.

Who are Tata Memorial Hospital's main competitors?

Direct peers on record are HealthCare Global Enterprises (HCG), Rajiv Gandhi Cancer Institute and Research Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, Tata Memorial Hospital — AIIMS (All India Institute of Medical Sciences) and Christian Medical College (CMC) Vellore. Broad incumbents are Max Healthcare Institute, Apollo Hospitals Enterprise, Fortis Healthcare, Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center.

Does Tata Memorial Hospital have an API?

No public API is recorded for Tata Memorial Hospital.

What industry is Tata Memorial Hospital in?

Tata Memorial Hospital's product category is Cancer Hospital Services. Its primary akta.pro industry code is HLADAHAG, Hospital-Based Palliative Care (Inpatient Consult Services). Its NAICS code is 622310 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaTMC Recruitment 2026 notification out for 57 posts, apply online before October 28Tata Memorial Centre released a recruitment notification for 57 vacancies across medical, scientific, administrative, and technical posts. Online applications are open until October 28, 2026, with a fee of Rs. 300 for most categories. Candidates must check post-specific eligibility criteria before applying.Medical BuyerTMC expanding cancer-care facilities; NCG connects 300 centresUnion Minister Jitendra Singh inaugurated a day-care cancer facility at Vidisha Medical College, Madhya Pradesh, with Tata Memorial Centre support. The facility is part of a phased expansion, with a radiotherapy facility expected within two to three years. The National Cancer Grid now connects over 380 cancer centres.My Jammu Links NewsDr Jitendra inaugurates ‘Cancer Centre’ in Vidisha (MP), seeks cooperation from society, citizensDr. Jitendra Singh inaugurated a day-care cancer facility at Vidisha Medical College, Madhya Pradesh, with technical support from Tata Memorial Centre. The facility is part of a phased expansion, with a linear accelerator radiotherapy facility expected within two to three years. The initiative aims to bring cancer care closer to home, addressing India's projected two million new cases annually by 2030.The Times of IndiaCAG flags inability to protect sensitive data after ransomware attack at Punjab cancer centreThe Comptroller and Auditor General flagged cybersecurity gaps at Tata Memorial Centre after a ransomware attack on Dec 2, 2024, at Homi Bhabha Cancer Hospital Research Centre, New Chandigarh, which disrupted IT systems. About 95% of services were restored by Dec 12, 2024, but the centre said no root-cause analysis had been done. CAG recommended multi-factor authentication, patching and regular monitoring.New Indian Express‘Made in India’ CAR-T therapy offers long-term blood cancer control: StudyA study of 250 patients across India demonstrates that NexCAR19, an indigenous CAR-T therapy developed by ImmunoACT and Tata Memorial Hospital, offers significant long-term control for relapsed or refractory blood cancers. The treatment, which costs approximately one-tenth of Western alternatives, showed high efficacy with 88% of leukemia patients seeing cancer shrink within 28 days and sustained remission for many up to 27 months. This data supports the scalability of centralized CAR-T delivery models, enabling broader access in India and expanding into international markets such as Africa through partnerships like the one with Cipla.New Indian ExpressPatients of blood cancer show positive response to IIT’s inexpensive therapyA study published in Nature’s Blood Cancer Journal indicates that NexCAR19, an inexpensive 'Made in India' CAR-T therapy developed by ImmunoACT and Tata Memorial Hospital, effectively treats blood cancer. The research, involving 250 patients across multiple Indian centers, found that 88% of those with relapsed or refractory B-cell acute lymphoblastic leukemia saw significant cancer shrinkage within 28 days.The Times of IndiaHuman judgement must supersede AI data, Tata Memorial Hospital director tells graduating TISS classDr. C.S. Pramesh, Director of Tata Memorial Hospital, addressed the 86th convocation of the Tata Institute of Social Sciences (TISS), urging graduates to prioritize human judgment over artificial intelligence in serving society. The ceremony also announced the establishment of a new Centre for AI and a think tank, while highlighting a staffing deficit at the institution. A posthumous degree was awarded to a victim of a recent fire in Delhi during the event.The HinduPartnership to improve access to natural human hair wigs for patients with cancerTata Memorial Centre and The Cherian Foundation have entered a partnership to provide premium natural human hair wigs to economically disadvantaged cancer patients across India. Under the agreement, The Cherian Foundation is donating 500 wigs valued at ₹1.5 crore and committing to manufacture and donate 1,000 wigs annually through its 'Gift Hair Gift Confidence' initiative. Tata Memorial Hospital will serve as the nodal agency for coordinating the distribution of these wigs within its network.BusinessLineHow a free wig initiative is centring the quality of life of cancer patientsTata Memorial Centre has partnered with The Cherian Foundation to distribute free, premium natural human hair wigs to economically disadvantaged cancer patients across its network. The initiative involves the donation of 500 wigs valued at ₹1.5 crore, with a commitment to provide 1,000 wigs annually to address the high costs and emotional impact of hair loss during chemotherapy.RediffTISS replaces CJI Surya Kant as chief guest amid rowThe Tata Institute of Social Sciences (TISS) appointed Dr C S Pramesh, director of Tata Memorial Hospital, as the new chief guest for its 86th Convocation on August 22. This change followed the postponement of the original event and the inability of Chief Justice of India Surya Kant to attend due to scheduling conflicts.